Neuropsychopharmacology
- Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum11 months ago
- Microglia as critical mediators linking perinatal immune stress to mental health trajectories11 months ago
- A biological blind spot in addiction research: hormonal contraceptives and adolescent reward seeking11 months ago
- nNOS-expressing neurons in the mPFC mediate depression-related behaviors in mice through pPVT-mPFC projections11 months ago
- Developmental sterol biosynthesis inhibition: are prescription medications as safe as we think?11 months ago
- Distinct subpopulations of parvalbumin neurons participating in divergent prefrontal functions11 months ago
- Cocaine self-administration in adult female and male rhesus monkeys: longitudinal comparison with adolescent behavior and role of early life stress11 months ago
Journal of Psychopharmacology
- Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin2 years ago
- Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?2 years ago
- High-dose Vitamin-B6 reduces sensory over-responsivity2 years ago
- Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes2 years ago
- Common protein networks for various drug regimens of major depression are associated with complement and immunity2 years ago
- Regular cannabis use modulates gamma activity in brain regions serving motor control2 years ago
- Psilocybin for clinical indications: A scoping review2 years ago
European Neuropsychopharmacology
- The challenges of using machine learning models in psychiatric research and clinical practice2 years ago
- Donanemab: An innovative solution for Alzheimer’s disease?2 years ago
- Therapeutic effectiveness of anti-inflammatory monoclonal antibodies in psychiatric disorders: Challenges with an imbalanced immune system2 years ago
- GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review2 years ago
- Treatment or enhancement? The controversial role of medication in personality disorders2 years ago
- Ensuring safety in cannabinoid prescriptions: A call for critical assessment2 years ago
- Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition2 years ago